Atlas Trials

Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled Trial

Clinical trial NCT06851078 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06851078
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Septic Shock
Start date
2025-03-15
Primary completion
2027-06-15
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.